We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Apr 20
Merck’s supplemental biologics license application (sBLA) for KEYTRUDA has been acepted by FDA as monotherapy for patients with…
07 Apr 20
The clinical study is aimed at evaluating efficacy and safety of Hope’s autologous, adipose-derived mesenchymal stem cells (HB-adMSCs)
07 Apr 20
Both GSK, Vir Biotechnology will apply their combined expertise to research on vaccines for SARS-CoV-2 and other coronaviruses
06 Apr 20
Rybelsus, which is currently being reviewed by regulatory agencies, including the Japanese Pharmaceuticals and Medical Devices Agency
06 Apr 20
Samsung will provide the full scope of its CDO services including cell line development, process development, cGMP clinical…
03 Apr 20
The late-stage trial will evaluate the use of Jakavi for the treatment of cytokine storm associated with the…
03 Apr 20
The companies will combine expertise to discover and develop fully human neutralising antibodies targeting SARS-CoV-2
02 Apr 20
FDA advises consumers, patients and health care professionals to withdraw Ranitidine, following the latest studies demonstrating risk to…
31 Mar 20
Taltz is a monoclonal antibody designed to selectively bind with interleukin 17A (IL-17A) and inhibit its interaction with…
31 Mar 20
Imfinzi is the only available immunotherapy that shows survival benefit in combination with etoposide and a choice of…